<DOC>
	<DOCNO>NCT02669888</DOCNO>
	<brief_summary>Atopic dermatitis ( AD ) chronic inflammatory skin disorder commonly occur child . The aim project : 1 . To evaluate efficacy indigo naturalis ointment treat AD topically ; 2 . To evaluate safety indigo naturalis ointment treat AD topically ; 3 . To investigate whether indigo naturalis ointment treatment associate change total IgE , cytokine , eosinophil , CRP patient AD ; 4 . To evaluate whether indigo naturalis ointment treatment improve quality life patient AD .</brief_summary>
	<brief_title>Indigo Naturalis Treating Atopic Dermatitis Topically</brief_title>
	<detailed_description>Atopic dermatitis ( AD ) chronic inflammatory skin disorder commonly occur child . AD characterize itchy dry skin affect approximately 5 20 % child world . Currently , corticosteroids widely prescribe medication treat AD ; however , concern regard side effect skin atrophy , telangiectasia , stria , folliculitis adrenocortical suppression inhibits growth child . Many patient family seek complementary alternative medication traditional Chinese medicine ( TCM ) . In TCM , indigo naturalis use treat various infectious inflammatory skin diseases hundred year . Ancient TCM literature record indigo naturalis also effective treat facial eczema ( AD ) infant . The aim project : ( 1 ) To evaluate efficacy indigo naturalis ointment treat AD topically ; ( 2 ) To evaluate safety indigo naturalis ointment treat AD topically ; ( 3 ) To investigate whether indigo naturalis ointment treatment associate change total IgE , cytokine , eosinophil , CRP patient AD ; ( 4 ) To evaluate whether indigo naturalis ointment treatment improve quality life patient AD .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>1 . Between 6 65 year old , female male . 2 . Atopic dermatitis fulfil diagnostic criterion Williams et al . 3 . Atopic dermatitis involve &lt; 40 % BSA . ( Base BSA result Screening ) 4 . An Investigator 's Global Assessment ( IGA ) score 2 , 3 4 corresponds mild , moderate severe disease . ( Base IGA result Screening ) 5 . Female patient childbearing age negative pregnancy test screening . 6 . Female patient childbearing age agree continue use birth control measure approve investigator agree lactate duration study . 7 . Agree receive stable dos additivefree , basic bland emollient least 7 day baseline ( day0 ) 8 . Willing comply study protocol agree sign inform consent form . 1 . Having history topical systematical hypersensitivity indigo naturalis excipient ( e.g . beeswax ) ointment 2 . Undergoing phototherapy ( e.g . UVB , PUVA ) systemic therapy ( e.g . Immunosuppressive agent ) within 30 day . 3 . Having use topical therapy ( e.g . topical corticosteroid ) dermatitis within 7 day first application study medication . 4 . Having significant concurrent disease , : significant abnormality hematology , severe uncontrolled metabolic syndrome ( e.g. , hypertension , diabetes mellitus , metabolic arthritis , hyperthyroidism ) , psychiatric disease , cancer AIDS . 5 . Having abnormal liver renal function ( AST/ALT &gt; 3 x ULN , creatinine &gt; 2.0 mg/dl ) . 6 . Women lactate , pregnant preparing pregnant .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Indigo Naturalis</keyword>
	<keyword>Atopic Dermatitis</keyword>
	<keyword>TCM</keyword>
</DOC>